AWM
BIIB icon

Absher Wealth Management’s Biogen BIIB Stock Holding History

Absher Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,304
Closed -$652K – 59
2021
Q3 		$652K Buy
2,304
+127
+6% +$41.6K 0.12% 44
2021
Q2 		$754K Buy
2,177
+233
+12% +$70.6K 0.13% 44
2021
Q1 		$544K Buy
1,944
+346
+22% +$93.3K 0.1% 45
2020
Q4 		$391K Sell
1,598
-475
-23% -$123K 0.08% 56
2020
Q3 		$588K Buy
2,073
+21
+1% +$5.86K 0.14% 41
2020
Q2 		$549K Buy
2,052
+88
+4% +$26.5K 0.14% 41
2020
Q1 		$621K Buy
1,964
+17
+0.9% +$5.16K 0.19% 37
2019
Q4 		$549K Buy
+1,947
New +$540K 0.14% 40

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Absher Wealth Management's BIIB Position: Q4 2021 in Review

Absher Wealth Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 2,304 shares — an estimated $652K sold.

Absher Wealth Management first reported a position in BIIB in Q4 2019 and held it in 8 quarters. The position peaked at $754K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Absher Wealth Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Absher Wealth Management sold 2,304 Biogen shares in Q4 2021, an estimated $652K.
  • Absher Wealth Management first reported a position in Biogen in Q4 2019 and held it in 8 quarters.
  • Absher Wealth Management's Biogen position peaked at $754K in Q2 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Absher Wealth Management's 13F filing for Q4 2021, filed 18 Jan 2022.